Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Annals of Pancreatic Cancer is Scopus-indexed (Q4, CiteScore 0.8). Published by AME Publishing Company.
Checked against the index lists dated .
ISSN 2616-2741Verify ISSN ↗
Publisher: AME Publishing Company
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Internal Medicine | 140 / 179 | 22nd | Q4 |
| Oncology | 355 / 428 | 17th | Q4 |
| Endocrinology, Diabetes and Metabolism | 208 / 250 | 17th | Q4 |
| Endocrinology | 123 / 132 | 7th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2018–present, best quartile Q4, CiteScore 0.8.
Annals of Pancreatic Cancer is Q4 in Internal Medicine (rank 140 of 179), Q4 in Oncology (rank 355 of 428) and Q4 in Endocrinology, Diabetes and Metabolism (rank 208 of 250), by CiteScore 2025. It is ranked in 4 subject areas in all.
Annals of Pancreatic Cancer is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.8, quartile Q4, 22nd percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.199, quartile Q3, with an H-index of 8.
Annals of Pancreatic Cancer is published by AME Publishing Company. Its ISSN is 2616-2741.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Annals of Pancreatic Cancer has an h-index of 10 and a 2-year mean of 0.59 citations per paper (OpenAlex). Its Scopus CiteScore is 0.8, quartile Q4. On 2-year citations it ranks #125 of 172 Scopus journals in Internal Medicine.
Annals of Pancreatic Cancer published 15 papers in 2025; its busiest recent year was 2018 with 166. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 52 research articles (2021–2026), authors are most often from United States (64.1%), United Kingdom (7.9%) and China (7.4%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.